Fig. 4From: The convergent application of metabolites from Avena sativa and gut microbiota to ameliorate non-alcoholic fatty liver disease: a network pharmacology studyThe GM or AS- a key signaling pathway-targets-SMs (GASTM) network (122 nodes and 155 edges)Back to article page